Device Trial Radar · NCT06332885
Zephyr Valve Japan Post-Marketing Surveillance
Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
Mar 12, 2024
Primary completion
Mar 31, 2027
Study completion Mar 31, 2028
Sponsor
- Lead sponsor
- Pulmonx CorporationPublic (LUNG)
- Sponsor type
- Industry
- First posted
- Mar 27, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20 centers across Japan and followed for 12 months.
Conditions
- Emphysema
- COPD
- Severe Emphysema
Interventions
Zephyr Endobronchial ValveDevice
Zephyr Valve provides an alternative technique to achieve bronchoscopic lung volume reduction (BLVR) using a minimally invasive approach. Zephyr Valve is a tiny unidirectional valve. During BLVR, multiple valves are placed to occlude a hyperinflated lobe of the lungs, allowing air to escape while blocking airflow into the treated lobe. This is intended to result in a reduction in lung volume and hyperinflation in the targeted area. Consequently, the remaining lobes can expand more fully, the overall lung works more efficiently, with resultant improvement in overall lung function in patients with hyperinflation associated with severe emphysema.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence rate of pneumothorax at 45-days post-Zephyr Valve index procedure.Time frame: 45-days post-Zephyr Valve index procedure
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Tosei General Hospital
Aichi, Japan · Recruiting
Gifu Prefectural Medical Center
Gifu, Japan · Recruiting
Kanagawa Cardio Chest Center
Kanagawa, Japan · Recruiting
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.